TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 4 | -0 | 19 | 12 | 75 | 95 | 56 | 43 |
| P | %wins | 75 | 100 | 75 | 50 | 50 | 50 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/17/15 11:32 | 12/16/15 | ARGS | Argos Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Winterbottom Joan | NC | O | CHRO | P | 0 | 1.83 | 0 | 0 | 100 | 1 | I | -81 | -78 | -74 | -67 | -58 | -45 | -28 | 9 | 47 | 28 | 192 | 232 | 163 | |
12/16/15 10:43 | 12/14/15 | ARGS | Argos Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Winterbottom Joan | NC | O | CHRO | P | 1 | 2.15 | 0 | 0 | New | 0 | I | -77 | -76 | -70 | -64 | -52 | -47 | -24 | -11 | 23 | 5 | 158 | 205 | 139 | |
8/27/15 11:54 | 8/24/15 | ARGS | Argos Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Winterbottom Joan | NC | O | CHRO | P | 6 | 6.10 | 0 | 1 | New | 1 | D | -30 | -33 | -23 | -7 | 2 | 38 | 0 | 0 | 1 | -9 | -36 | -34 | -24 | |
11/14/12 11:29 | 11/13/12 | FOLD | Amicus Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Winterbottom Joan | NJ | O | SVP,HR | P | 8 | 4.54 | 3 | 2 | New | 2 | D | 3 | 60 | -11 | -13 | -14 | -24 | -11 | -7 | 1 | 3 | 23 | -13 | -24 | -53 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |